HOME > MARKETS > DRUG DISCOVERY

Drug Discovery

NEUROSERVICE's expertise is focused on compound interaction with the CNS.

NEUROSERVICE's High-Quality service is aimed at any Pharmaceutical Industry interested in evaluating the impact of its molecules on the CNS.

From one-shot standardized tests to global solution with customized tests and high production volume, NEUROSERVICE can help you save time and money.
NEUROSERVICE delivers assays for each step of drug development processes.

Lead selection and Lead optimization: to fire very early compounds presenting undesirable effects on the CNS, rescue and optimize backup molecules on the basis of functional pharmacological tests.

"Special Biotech Offer"

Discount prices
Data generated within 6 months
but without a precise date of release
Data communicated in basic format
(graphs and tables) and no study report

Preclinical Development: to document further on a complex neuronal network, up to single protein level, CNS effects observed in animal testing.

Phase 1 and Phase 2 : to investigate and identify sources and mechanisms of action in CNS side effects and possible drug-drug interactions.

NEUROSERVICE offers standardized tests, as well as customized protocols, and is able to perform a large number of tests in short delays.

Raw data can be generated and transmitted without any further analysis or comments for companies with in-house expertise.

Most of biotech companies have no facilities or expertise in the field of electrophysiology. NEUROSERVICE provides complete support for test design and realization, as well as data analysis and scientific support for Drug Discovery programs. The tests can be designed or optimized according to the diseases or targets you are working on.